Progyny (PGNY) Operating Expenses (2018 - 2026)

Progyny (PGNY) has reported Operating Expenses for 9 consecutive years, with $49.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Expenses fell 9.74% year-over-year to $49.3 million in Q2 2026; TTM through Jun 2026 was $210.0 million, a 4.63% increase from a year earlier, with the FY2025 full-year figure at $219.2 million, up 17.91% from the prior year.
• Operating Expenses was $49.3 million for Q2 2026 at Progyny, up from $47.7 million in the prior quarter.
• Over five years, Operating Expenses peaked at $61.7 million in Q4 2025 and troughed at $33.0 million in Q1 2022.
• A 5-year average of $45.7 million and a median of $46.1 million in 2023 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses surged 95.1% in 2022 and slipped 9.74% in 2026, its largest moves.
• Over 5 years, Operating Expenses stood at $41.2 million in 2022, then rose by 4.63% to $43.1 million in 2023, then climbed by 10.56% to $47.6 million in 2024, then rose by 29.41% to $61.7 million in 2025, then retreated by 20.05% to $49.3 million in 2026.
• The last three Operating Expenses figures came in at $49.3 million (Q2 2026), $47.7 million (Q1 2026), and $61.7 million (Q4 2025), per Business Quant data.